Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Dermorphin
Course Target: Neuropharmacology, Opioidergic Signaling, and Bioactive Amphibian Toxins.
Core Focal Point: Selective \(\mu \)-Opioid Agonism, Post-Translational Epimerization, and Hyper-Analgesia.
1. Molecular Structure, Origin, & The "Enigma"
Dermorphin is a 7-amino acid heptapeptide (Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH₂) originally isolated in 1981 from the skin of the South American waxy monkey tree frog (Phyllomedusa sauvagei).
The D-Amino Acid Phenomenon: Human DNA only codes for left-handed amino acids (L-isomers). However, Dermorphin features D-Alanine at its second position.
The Biosynthetic Trick: The frog's genes actually code for standard L-Alanine. After the peptide is built, a highly rare enzyme in the frog's skin physically flips the molecule into its mirror-image D-form.
2. 🎯 The Cellular Mechanism: The Ultra-Lock
To explain its extreme potency to your class, use the phrase "The Stereospecific Lock." Dermorphin operates directly on the central nervous system's primary pain-blocking hardware:
[Dermorphin Administered (Exogenous/Frog Toxin)]
│
▼
[Bypasses Rapid Peptidase Destruction (D-Ala Shield)]
│
▼
[Selectively Binds to μ-Opioid Receptors (MOR) in Brain/Spine]
│
▼
[Inhibits Adenylate Cyclase & Blocks Calcium Influx]
│
▼
[Shuts Down Thalamic Firing ──► 30x to 2,000x Potency of Morphine]
Step 1: The Enzymatic Shield
When standard peptides enter the body, protective enzymes (peptidases) immediately tear them apart. Because enzymes are strictly designed to cut L-amino acids, they do not recognize Dermorphin's D-Alanine. This allows Dermorphin to survive un-degraded in biological fluids for long windows.
Step 2: Severe Receptor Affinity
The D-Alanine residue locks the peptide's N-terminal sequence (Tyr-D-Ala-Phe) into a highly specific geometric shape. This shape fits into the \(\mu \)-Opioid Receptors (MOR) on neurons with near-perfect complementary binding affinity—roughly 100 times tighter than morphine.
Step 3: Pain Signal Erasure
Binding to MOR triggers an intracellular G-protein cascade that inhibits adenylate cyclase, closes voltage-gated calcium channels, and opens potassium channels. This hyperpolarizes the nerve cell, completely blocking the nucleus from firing or transmitting painful electrical messages to the brain.
3. Efficacy vs. Morphine (Shocking Lecture Statistics)
Your class will find its raw analgesic power staggering compared to traditional painkillers:
In Vitro (Isolated Tissue): Dermorphin is 30 to 40 times more potent than morphine.
Central Administration (In the Brain/Spine): When injected directly into the central nervous system in rodent models, Dermorphin behaves between 752 and 2,170 times more potent than morphineat obliterating pain perception.
Duration: A single localized dose blocks pain pathways for roughly double the duration of a matched dose of morphine.
RISK.
it can cause severe tachycardia, violent vomiting, and dangerous blood pressure drops.
Addiction and Tolerance: While early research suggested it caused less respiratory depression than morphine, repeated central use still triggers severe opioid tolerance, physical dependence, and intense withdrawal symptoms upon cessation.
Product Details
• Compound: DERMORPHIN
• Quantity: 10 mg
• Form: Lyophilized Powder
• Purity: ≥99% (if applicable)
• Storage: Store in a controlled laboratory environment, protected from light and moisture
Research Use Only
This product is intended strictly for laboratory research use only.
Not for human consumption.
Not for medical use.
Not intended to diagnose, treat, cure, or prevent any disease.
Not approved by the FDA.
This product is in powder form and is not reconstituted. All materials sold on this site are for laboratory research purposes only and are subject to our Terms and Conditions.
By purchasing, the buyer confirms this product will be used strictly for laboratory research purposes.
Dermorphin
Course Target: Neuropharmacology, Opioidergic Signaling, and Bioactive Amphibian Toxins.
Core Focal Point: Selective \(\mu \)-Opioid Agonism, Post-Translational Epimerization, and Hyper-Analgesia.
1. Molecular Structure, Origin, & The "Enigma"
Dermorphin is a 7-amino acid heptapeptide (Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH₂) originally isolated in 1981 from the skin of the South American waxy monkey tree frog (Phyllomedusa sauvagei).
The D-Amino Acid Phenomenon: Human DNA only codes for left-handed amino acids (L-isomers). However, Dermorphin features D-Alanine at its second position.
The Biosynthetic Trick: The frog's genes actually code for standard L-Alanine. After the peptide is built, a highly rare enzyme in the frog's skin physically flips the molecule into its mirror-image D-form.
2. 🎯 The Cellular Mechanism: The Ultra-Lock
To explain its extreme potency to your class, use the phrase "The Stereospecific Lock." Dermorphin operates directly on the central nervous system's primary pain-blocking hardware:
[Dermorphin Administered (Exogenous/Frog Toxin)]
│
▼
[Bypasses Rapid Peptidase Destruction (D-Ala Shield)]
│
▼
[Selectively Binds to μ-Opioid Receptors (MOR) in Brain/Spine]
│
▼
[Inhibits Adenylate Cyclase & Blocks Calcium Influx]
│
▼
[Shuts Down Thalamic Firing ──► 30x to 2,000x Potency of Morphine]
Step 1: The Enzymatic Shield
When standard peptides enter the body, protective enzymes (peptidases) immediately tear them apart. Because enzymes are strictly designed to cut L-amino acids, they do not recognize Dermorphin's D-Alanine. This allows Dermorphin to survive un-degraded in biological fluids for long windows.
Step 2: Severe Receptor Affinity
The D-Alanine residue locks the peptide's N-terminal sequence (Tyr-D-Ala-Phe) into a highly specific geometric shape. This shape fits into the \(\mu \)-Opioid Receptors (MOR) on neurons with near-perfect complementary binding affinity—roughly 100 times tighter than morphine.
Step 3: Pain Signal Erasure
Binding to MOR triggers an intracellular G-protein cascade that inhibits adenylate cyclase, closes voltage-gated calcium channels, and opens potassium channels. This hyperpolarizes the nerve cell, completely blocking the nucleus from firing or transmitting painful electrical messages to the brain.
3. Efficacy vs. Morphine (Shocking Lecture Statistics)
Your class will find its raw analgesic power staggering compared to traditional painkillers:
In Vitro (Isolated Tissue): Dermorphin is 30 to 40 times more potent than morphine.
Central Administration (In the Brain/Spine): When injected directly into the central nervous system in rodent models, Dermorphin behaves between 752 and 2,170 times more potent than morphineat obliterating pain perception.
Duration: A single localized dose blocks pain pathways for roughly double the duration of a matched dose of morphine.
RISK.
it can cause severe tachycardia, violent vomiting, and dangerous blood pressure drops.
Addiction and Tolerance: While early research suggested it caused less respiratory depression than morphine, repeated central use still triggers severe opioid tolerance, physical dependence, and intense withdrawal symptoms upon cessation.
Product Details
• Compound: DERMORPHIN
• Quantity: 10 mg
• Form: Lyophilized Powder
• Purity: ≥99% (if applicable)
• Storage: Store in a controlled laboratory environment, protected from light and moisture
Research Use Only
This product is intended strictly for laboratory research use only.
Not for human consumption.
Not for medical use.
Not intended to diagnose, treat, cure, or prevent any disease.
Not approved by the FDA.
This product is in powder form and is not reconstituted. All materials sold on this site are for laboratory research purposes only and are subject to our Terms and Conditions.
By purchasing, the buyer confirms this product will be used strictly for laboratory research purposes.